ATM deficiency results in accumulation of DNA-topoisomerase I covalent intermediates in neural cells

PLoS One. 2013 Apr 23;8(4):e58239. doi: 10.1371/journal.pone.0058239. Print 2013.

Abstract

Accumulation of peptide-linked DNA breaks contributes to neurodegeration in humans. This is typified by defects in tyrosyl DNA phosphodiesterase 1 (TDP1) and human hereditary ataxia. TDP1 primarily operates at single-strand breaks (SSBs) created by oxidative stress or by collision of transcription machinery with topoisomerase I intermediates (Top1-CCs). Cellular and cell-free studies have shown that Top1 at stalled Top1-CCs is first degraded to a small peptide resulting in Top1-SSBs, which are the primary substrates for TDP1. Here we established an assay to directly compare Top1-SSBs and Top1-CCs. We subsequently employed this assay to reveal an increased steady state level of Top1-CCs in neural cells lacking Atm; the protein mutated in ataxia telangiectasia. Our data suggest that the accumulation of endogenous Top1-CCs in Atm-/- neural cells is primarily due to elevated levels of reactive oxygen species. Biochemical purification of Top1-CCs from neural cell extract and the use of Top1 poisons further confirmed a role for Atm during the formation/resolution of Top1-CCs. Finally, we report that global transcription is reduced in Atm-/- neural cells and fails to recover to normal levels following Top1-mediated DNA damage. Together, these data identify a distinct role for ATM during the formation/resolution of neural Top1-CCs and suggest that their accumulation contributes to the neuropathology of ataxia telangiectasia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Astrocytes / pathology
  • Ataxia Telangiectasia Mutated Proteins / antagonists & inhibitors
  • Ataxia Telangiectasia Mutated Proteins / deficiency
  • Ataxia Telangiectasia Mutated Proteins / genetics*
  • Biological Assay
  • Camptothecin / pharmacology
  • Cell Line
  • DNA Breaks, Single-Stranded
  • DNA Topoisomerases, Type I / genetics*
  • DNA Topoisomerases, Type I / metabolism
  • Enzyme Inhibitors / pharmacology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fibroblasts / pathology
  • Gene Expression Regulation*
  • Humans
  • Morpholines / pharmacology
  • Oxidative Stress
  • Phosphoric Diester Hydrolases / genetics*
  • Phosphoric Diester Hydrolases / metabolism
  • Pyrones / pharmacology
  • Signal Transduction
  • Topoisomerase I Inhibitors / pharmacology
  • Transcription, Genetic

Substances

  • 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one
  • Enzyme Inhibitors
  • Morpholines
  • Pyrones
  • Topoisomerase I Inhibitors
  • ATM protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • Phosphoric Diester Hydrolases
  • TDP1 protein, human
  • DNA Topoisomerases, Type I
  • TOP1 protein, human
  • Camptothecin